Financials
Income statement
| Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
|---|---|---|---|---|
| Total reported revenue | 423.6M | 354.7M | 316.3M | 335.1M |
| Cost of revenue | 64.5M | 63.8M | 63.3M | 55.3M |
| Gross profit | 359.1M | 290.9M | 252.9M | 279.8M |
| Operating expense | ||||
| Research & development | 99.7M | 97.0M | 98.4M | 85.6M |
| Selling general and admin | 225.8M | 237.3M | 257.8M | 243.6M |
| Other operating expenses | — | — | — | — |
| Operating income | 33.6M | -43.4M | -103.3M | -49.5M |
| Non operating interest income | ||||
| Income | 12.2M | 10.1M | 13.4M | 13.8M |
| Expense | — | — | — | — |
| Other income expense | 8.8M | 7.8M | 7.7M | 10.7M |
| Pretax income | 54.6M | -25.5M | -82.3M | -25.0M |
| Tax provision | 2.8M | -14.8M | 3.8M | 3.8M |
| Net income | 51.8M | -10.7M | -86.1M | -28.7M |
| Basic EPS | 0.1 | 0.0 | -0.2 | -0.1 |
| Diluted EPS | 0.1 | 0.0 | -0.2 | -0.1 |
| Basic average shares | 28.3M | 28.3M | 29.1M | 29.2M |
| Diluted average shares | 28.5M | 28.3M | 29.1M | 29.2M |
| EBITDA | 36.8M | -38.8M | -98.8M | -44.6M |
| Net income from continuing op. | 51.8M | -10.7M | -86.1M | -28.7M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |